About entanglement properties of kaons and tests of hidden variables models

In this letter we discuss entanglement properties of neutral kaons systems and their use for testing local realism. In particular we show that, as previous proposals, also a scheme recently suggested for performing a test of hidden variable theories against standard quantum mechanics cannot be conclusive

Nondemolition Principle of Quantum Measurement Theory

We give an explicit axiomatic formulation of the quantum measurement theory which is free of the projection postulate. It is based on the generalized nondemolition principle applicable also to the unsharp, continuous-spectrum and continuous-in-time observations. The "collapsed state-vector" after the "objectification" is simply treated as a random vector of the a posteriori state given by the quantum filtering, i.e., the conditioning of the a priori induced state on the corresponding reduced algebra. The nonlinear phenomenological equation of "continuous spontaneous localization" has been derived from the Schroedinger equation as a case of the quantum filtering equation for the diffusive nondemolition measurement. The quantum theory of measurement and filtering suggests also another type of the stochastic equation for the dynamical theory of continuous reduction, corresponding to the counting nondemolition measurement, which is more relevant for the quantum experiments.Comment: 23 pages. See also related papers at http://www.maths.nott.ac.uk/personal/vpb/research/mes_fou.html and http://www.maths.nott.ac.uk/personal/vpb/research/cau_idy.htm

Review of recent experimental progresses in Foundations of Quantum Mechanics and Quantum Information obtained in Parametric Down Conversion Experiments at IENGF

We review some recent experimental progresses concerning Foundations of Quantum Mechanics and Quantum Information obtained in Quantum Optics Laboratory "Carlo Novero" at IENGF. More in details, after a short presentation of our polarization entangled photons source (based on precise superposition of two Type I PDC emission) and of the results obtained with it, we describe an innovative double slit experiment where two degenerate photons produced by PDC are sent each to a specific slit. Beyond representing an interesting example of relation between visibility of interference and "welcher weg" knowledge, this configuration has been suggested for testing de Broglie-Bohm theory against Standard Quantum Mechanics. Our results perfectly fit SQM results, but disagree with dBB predictions. Then, we discuss a recent experiment addressed to clarify the issue of which wave-particle observables are really to be considered when discussing wave particle duality. This experiments realises the Agarwal et al. theoretical proposal, overcoming limitations of a former experiment. Finally, we hint to the realization of a high-intensity high-spectral-selected PDC source to be used for quantum information studies

Chronic kidney disease in children: the global perspective

In contrast to the increasing availability of information pertaining to the care of children with chronic kidney disease (CKD) from large-scale observational and interventional studies, epidemiological information on the incidence and prevalence of pediatric CKD is currently limited, imprecise, and flawed by methodological differences between the various data sources. There are distinct geographic differences in the reported causes of CKD in children, in part due to environmental, racial, genetic, and cultural (consanguinity) differences. However, a substantial percentage of children develop CKD early in life, with congenital renal disorders such as obstructive uropathy and aplasia/hypoplasia/dysplasia being responsible for almost one half of all cases. The most favored end-stage renal disease (ESRD) treatment modality in children is renal transplantation, but a lack of health care resources and high patient mortality in the developing world limits the global provision of renal replacement therapy (RRT) and influences patient prevalence. Additional efforts to define the epidemiology of pediatric CKD worldwide are necessary if a better understanding of the full extent of the problem, areas for study, and the potential impact of intervention is desired

Hypertension in children with chronic kidney disease: pathophysiology and management

Arterial hypertension is very common in children with all stages of chronic kidney disease (CKD). While fluid overload and activation of the renin–angiotensin system have long been recognized as crucial pathophysiological pathways, sympathetic hyperactivation, endothelial dysfunction and chronic hyperparathyroidism have more recently been identified as important factors contributing to CKD-associated hypertension. Moreover, several drugs commonly administered in CKD, such as erythropoietin, glucocorticoids and cyclosporine A, independently raise blood pressure in a dose-dependent fashion. Because of the deleterious consequences of hypertension on the progression of renal disease and cardiovascular outcomes, an active screening approach should be adapted in patients with all stages of CKD. Before one starts antihypertensive treatment, non-pharmacological options should be explored. In hemodialysis patients a low salt diet, low dialysate sodium and stricter dialysis towards dry weight can often achieve adequate blood pressure control. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers are first-line therapy for patients with proteinuria, due to their additional anti-proteinuric properties. Diuretics are a useful alternative for non-proteinuric patients or as an add-on to renin–angiotensin system blockade. Multiple drug therapy is often needed to maintain blood pressure below the 90th percentile target, but adequate blood pressure control is essential for better renal and cardiovascular long-term outcomes

Therapeutic strategies to slow chronic kidney disease progression

Childhood chronic kidney disease commonly progresses toward end-stage renal failure, largely independent of the underlying disorder, once a critical impairment of renal function has occurred. Hypertension and proteinuria are the most important independent risk factors for renal disease progression. Therefore, current therapeutic strategies to prevent progression aim at controlling blood pressure and reducing urinary protein excretion. Renin-angiotensin-system (RAS) antagonists preserve kidney function not only by lowering blood pressure but also by their antiproteinuric, antifibrotic, and anti-inflammatory properties. Intensified blood pressure control, probably aiming for a target blood pressure below the 75th percentile, may exert additional renoprotective effects. Other factors contributing in a multifactorial manner to renal disease progression include dyslipidemia, anemia, and disorders of mineral metabolism. Measures to preserve renal function should therefore also comprise the maintenance of hemoglobin, serum lipid, and calcium-phosphorus ion product levels in the normal range

Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease

Chronic kidney disease (CKD) in children is irreversible. It is associated with renal failure progression and atherosclerotic cardiovascular (CV) abnormalities. Nearly 60% of children with CKD are affected since birth with congenital or inherited kidney disorders. Preliminary evidence primarily from adult CKD studies indicates common genetic risk factors for CKD and atherosclerotic CV disease. Although multiple physiologic pathways share common genes for CKD and CV disease, substantial evidence supports our attention to the renin angiotensin system (RAS) and the interlinked inflammatory cascade because they modulate the progressions of renal and CV disease. Gene polymorphisms in the RAS-cytokine pathway, through altered gene expression of inflammatory cytokines, are potential factors that modulate the rate of CKD progression and CV abnormalities in patients with CKD. For studying such hypotheses, the cooperative efforts among scientific groups and the availability of robust and affordable technologies to genotype thousands of single nucleotide polymorphisms (SNPs) across the genome make genome-wide association studies an attractive paradigm for studying polygenic diseases such as CKD. Although attractive, such studies should be interpreted carefully, with a fundamental understanding of their potential weaknesses. Nevertheless, whole-genome association studies for diabetic nephropathy and future studies pertaining to other types of CKD will offer further insight for the development of targeted interventions to treat CKD and associated atherosclerotic CV abnormalities in the pediatric CKD population